David Tapolczay

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
St. Albans, United Kingdom
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ David Tapolczay
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David Tapolczay

Form 4 holding Chief Executive Officer, Director

CONDUIT PHARMACEUTICALS INC.

Security class
Stock Option (Right to Buy)
Shares / value
840,000
Estimated value
$77,196
Report date
18 Nov 2024
Price
$0.0919
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

CONDUIT PHARMACEUTICALS INC.

Security class
Warrant (Right to buy)
Shares / value
200,332
Estimated value
Report date
22 Apr 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David Tapolczay

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .